Search By:
Products
Injury
Topic
Company
Industry
Purdue Pharmaceuticals may have defrauded the US Patent Office to obtain a patent on Oxycontin.
Investigation Source
- Nationwide
Investigation Scope
Category Information
Investigation Topics
- Over Charge
- Price Fixing
- Overcharging for Drug
Product or Service
- Oxycontin
Injury Type
- Monetary Loss
Investigation Details
Investigation and pending class action lawsuit on behalf of direct purchasers for the opioid analgensic, Oxycontin.
The class action complaint alleges that Purdue Pharmaceuticals, L.P. obtained patents protecting Oxycontin by defrauding the U.S. Patent and Trademark Office, leading it to believe the drug was novel, when in fact many prior opioid painkillers presaged Oxycontin.
Do not change medications without first consulting your doctor.
The class action complaint alleges that Purdue Pharmaceuticals, L.P. obtained patents protecting Oxycontin by defrauding the U.S. Patent and Trademark Office, leading it to believe the drug was novel, when in fact many prior opioid painkillers presaged Oxycontin.
Do not change medications without first consulting your doctor.
Defendant Details
| Name (Stock Symbol) | Brief Description |
|---|---|
| Purdue Pharmaceuticals | Purdue Pharmaceuticals is a pharmaceutical company. |